cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Baxter International Inc
14 own
22 watching
Current Price
$47.01
$0.73
(1.58%)
logo-bax
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
23,695.09M
52-Week High
52-Week High
89.7
52-Week Low
52-Week Low
43.25
Average Volume
Average Volume
8.99M
Dividend Yield
Dividend Yield
0.013455
P/E Ratio
P/E Ratio
32.5274
iconMarket Capitalization23,695.09M
icon52-Week High89.7
icon52-Week Low43.25
iconAverage Volume8.99M
iconDividend Yield0.013455
iconP/E Ratio32.5274
What does the Baxter International Inc do?
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Read More
How much money does Baxter International Inc make?
News & Events about Baxter International Inc.
Globe Newswire
2days ago
Combines Miromatrixs expertise in bioengineered organs with Baxters leadership in critical care delivery and organ support therapiesIncludes intended Phase I clinical trial designed to generate key evidence to support additional therapeutic options for patients suffering from acute liver failure ...
Zolmax
26days ago
Baxter International (NYSE:BAX Get Rating) was downgraded by investment analysts at Morgan Stanley from an overweight rating to an equal weight rating in a research note issued to investors on Friday, The Fly reports. They presently have a $55.00 price target on ...
Business Wire
28days ago
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced a comprehensive strategic roadmap to meaningfully enhance its operational effectiveness, drive toward improved long-term performance, accelerate innovation and create additional value for all stakeholders. These...
Business Wire
1month ago
Baxter International Inc. (NYSE: BAX), a global medtech leader, today announced it was again named to the Dow Jones Sustainability Indices (DJSI), including both DJSI World and DJSI North America. Baxter has proudly been included in the DJSI World and DJSI North America each year since they...
Ticker Report
2 months ago
Shares of Baxter International Inc. (NYSE:BAX Get Rating) have been assigned an average rating of Hold from the seventeen analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a...
Frequently Asked Questions
Frequently Asked Questions
What is Baxter International Inc share price today?
plus_minus_icon
Can Indians buy Baxter International Inc shares?
plus_minus_icon
How can I buy Baxter International Inc shares from India?
plus_minus_icon
Can Fractional shares of Baxter International Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Baxter International Inc stocks?
plus_minus_icon
What is today’s traded volume of Baxter International Inc?
plus_minus_icon
What is today’s market capitalisation of Baxter International Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Baxter International Inc?
plus_minus_icon
What percentage is Baxter International Inc down from its 52-Week High?
plus_minus_icon
What percentage is Baxter International Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$47.01
$0.73
(1.58%)
logo-bax
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00